Alimera Sciences (ALIM) Tops Q2 EPS by 2c

Alimera Sciences (NASDAQ: ALIM) reported Q2 EPS of ($0.17), $0.02 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $3.8 million versus the consensus estimate of $8.42 million.

For earnings history and earnings-related data on Alimera Sciences (ALIM) click here.

You May Also Be Interested In

• Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
• Exxon (XOM) shares slip as Q1 earnings falls short of analyst estimates
• Snap shares surge 26% on earnings beat, optimistic outlook